These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16226492)

  • 1. Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer.
    Yan Y; Rubinchik S; Wood AL; Gillanders WE; Dong JY; Watson DK; Cole DJ
    Mol Ther; 2006 Feb; 13(2):357-65. PubMed ID: 16226492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancer.
    Kelley JR; Brown JM; Frasier MM; Baron PL; Schweinfest CW; Vournakis JN; Watson DK; Cole DJ
    Surgery; 2000 Aug; 128(2):353-60. PubMed ID: 10923016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer.
    Kelley JR; Fraser MM; Hubbard JM; Watson DK; Cole DJ
    Anticancer Res; 2003; 23(3A):2007-13. PubMed ID: 12894573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing a murine pancreatic cancer CaSm model: up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinoma.
    Yan Y; Rubinchik S; Watson PM; Kelley JR; Fraser MM; Wood AL; Dong JY; Gillanders WE; Boylan AM; Watson DK; Cole DJ
    Mol Ther; 2005 Mar; 11(3):363-72. PubMed ID: 15727932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
    Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
    Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
    Fujita T; Timme TL; Tabata K; Naruishi K; Kusaka N; Watanabe M; Abdelfattah E; Zhu JX; Ren C; Ren C; Yang G; Goltsov A; Wang H; Vlachaki MT; Teh BS; Butler EB; Thompson TC
    Gene Ther; 2007 Feb; 14(3):227-36. PubMed ID: 17024109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.
    Schmitz V; Vilanueva H; Raskopf E; Hilbert T; Barajas M; Dzienisowicz C; Gorschlüter M; Strehl J; Rabe C; Sauerbruch T; Prieto J; Caselmann WH; Qian C
    Gene Ther; 2006 Aug; 13(16):1198-205. PubMed ID: 16617302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
    Egami T; Ohuchida K; Mizumoto K; Onimaru M; Toma H; Nishio S; Nagai E; Matsumoto K; Nakamura T; Tanaka M
    Clin Cancer Res; 2008 Mar; 14(6):1859-67. PubMed ID: 18347189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma.
    Stefani AL; Barzon L; Castagliuolo I; Guido M; Pacenti M; Parolin C; Farinati F; Palù G
    J Hepatol; 2005 May; 42(5):728-35. PubMed ID: 15826723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E; Unfer R; Vahanian N; Link C
    Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
    Hase R; Miyamoto M; Uehara H; Kadoya M; Ebihara Y; Murakami Y; Takahashi R; Mega S; Li L; Shichinohe T; Kawarada Y; Kondo S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8737-44. PubMed ID: 16361561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.
    Deharvengt S; Rejiba S; Wack S; Aprahamian M; Hajri A
    Int J Oncol; 2007 Jun; 30(6):1397-406. PubMed ID: 17487360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
    Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice.
    Naumann U; Bähr O; Wolburg H; Altenberend S; Wick W; Liston P; Ashkenazi A; Weller M
    Gene Ther; 2007 Jan; 14(2):147-61. PubMed ID: 16957768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes.
    Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
    Gene Ther; 2006 Aug; 13(16):1235-43. PubMed ID: 16617300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The feasibility and mechanism of recombinant adenovirus Ad - p 14 ARF in gene therapy of liver cancer].
    Song HF; Qian HL; Zhang XY; Liang X; Fu M; Lin C
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):641-5. PubMed ID: 17274365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal injection of adenovirus expressing antisense K-ras RNA suppresses peritoneal dissemination of hamster syngeneic pancreatic cancer without systemic toxicity.
    Miura Y; Ohnami S; Yoshida K; Ohashi M; Nakano M; Ohnami S; Fukuhara M; Yanagi K; Matsushita A; Uchida E; Asaka M; Yoshida T; Aoki K
    Cancer Lett; 2005 Jan; 218(1):53-62. PubMed ID: 15639340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer.
    Chen W; Yan C; Hou J; Pu J; Ouyang J; Wen D
    Urol Oncol; 2008; 26(4):397-405. PubMed ID: 18367126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
    Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
    J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective intratumoral amplification of an antiangiogenic vector by an oncolytic virus produces enhanced antivascular and anti-tumor efficacy.
    Thorne SH; Tam BY; Kirn DH; Contag CH; Kuo CJ
    Mol Ther; 2006 May; 13(5):938-46. PubMed ID: 16469543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.